Haemonetics HAE Income Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $1.33B+1.2% | $1.32B-0.7% | $1.33B-1.4% | $1.35B-1.1% | $1.36B-0.9% | ||
| $546.44M+2.0% | $535.85M-3.3% | $554.27M-4.4% | $579.77M-5.2% | $611.87M-4.6% | ||
| $787.59M+0.7% | $782.42M+1.1% | $773.59M+1.0% | $766.28M+2.3% | $748.96M+2.3% | ||
| 59%-0.3pp | 59.4%+1.1pp | 58.3%+1.3pp | 56.9%+1.9pp | 55%+1.8pp | ||
| $59.77M-6.1% | $63.63M-2.5% | $65.27M+1.1% | $64.53M+2.9% | $62.72M+4.1% | ||
| $442.42M+1.3% | $436.62M+0.6% | $433.93M-1.2% | $439.26M+0.6% | $436.79M+1.4% | ||
| $630.85M+18.7% | $531.33M+0.1% | $530.86M+0.1% | $530.35M+0.6% | $527.14M-4.4% | ||
| —— | $251.09M+3.4% | $242.73M+2.9% | $235.93M+6.4% | $221.82M+22.9% | ||
| -$28.7M-20.0% | -$23.93M+6.6% | -$25.62M-0.8% | -$25.41M-161% | -$9.75M+37.8% | ||
| —— | $227.17M+4.6% | $217.11M+3.1% | $210.53M-0.7% | $212.07M+28.7% | ||
| —— | $51.73M+5.7% | $48.92M+3.7% | $47.19M+6.3% | $44.39M+28.0% | ||
| —— | $175.44M+4.3% | $168.19M+3.0% | $163.34M-2.6% | $167.68M+28.9% | ||
| —— | $3.63+6.1% | $3.42+4.6% | $3.27-1.2% | $3.31+30.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.